If you've been researching GLP-1 treatment options, you've likely run into the terms "compounded" and "brand-name" without much explanation of what actually separates them. The difference matters — for cost, for regulation, and for what you're agreeing to when you start treatment. Here's a clear breakdown. What does "compounded medication" actually mean?

Polycystic ovary syndrome (PCOS) affects roughly 1 in 10 women of reproductive age, and for many, weight gain and insulin resistance are among the hardest symptoms to manage. As GLP-1 medications have become more widely prescribed, a growing body of research has started to look specifically at how they affect women with PCOS. Here's a clear look at what the science currently shows — and doesn't.